Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 2nd September 2020
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vetoquinol completes acquisition of Profender® and Drontal®
Vetoquinol has completed its acquisition of the Profender and Drontal product families.
“These two strong brands fit perfectly at the core of Vetoquinol strategy” - Matthieu Frechin.

Vetoquinol has completed its acquisition of Profender® and Drontal® product families, previously owned by Bayer Animal Health.

The acquisition is related to Elanco’s acquisition of Bayer AG’s animal health business, finalised on 1 August 2020. The Profender and Drontal families of products are spot-on and tablet de-wormer products for cats and dogs.

Vetoquinol CEO Matthieu Frechin said: "We are extremely pleased to share the completion of the acquisition of the Profender®and Drontal®product lines. These two strong brands fit perfectly at the core of Vetoquinol strategy.

“From now on, they will significantly increase the size of our business and our visibility in the parasiticide segment, one of our strategic therapeutic areas. Also, effectively immediately, these products and brands strengthen our portfolio of Essentials, the engine of our growth. I am proud of the Vetoquinol teams whom made this deal happen despite the challenging circumstances under the COVID global context.”

Elanco’s acquisition of Bayer Animal Health is valued at $6.89 billion. The transaction elevates Elanco’s pet business to approximately 50 per cent of revenues and almost triples the company’s international pet health business.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.